Hyperlipidemia News and Research

RSS
Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.
Risk factors for hospital readmissions identified in stroke patients

Risk factors for hospital readmissions identified in stroke patients

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

Sanford-Burnham, Daiichi enter into comprehensive alliance to develop first-in-class therapeutics

Sanford-Burnham, Daiichi enter into comprehensive alliance to develop first-in-class therapeutics

Free access to fitness center is not well utilized by low income community

Free access to fitness center is not well utilized by low income community

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Novel discovery could lead to new therapy to combat obesity, diabetes

Novel discovery could lead to new therapy to combat obesity, diabetes

UCSF/Daiichi Sankyo establish drug-discovery collaboration focused on neurodegenerative diseases

UCSF/Daiichi Sankyo establish drug-discovery collaboration focused on neurodegenerative diseases

Enrollment commences for Daiichi Sankyo's ENSURE-AF multinational phase 3 study in NVAF patients

Enrollment commences for Daiichi Sankyo's ENSURE-AF multinational phase 3 study in NVAF patients

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Treatable factors linked to blood pressure variability in diabetes

Treatable factors linked to blood pressure variability in diabetes

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

Research roundup: Value-based insurance; telemedicine in nursing homes; advance care planning

Research roundup: Value-based insurance; telemedicine in nursing homes; advance care planning

Blood pressure lowering linked with reduced risk for cognitive decline in patients with T2DM

Blood pressure lowering linked with reduced risk for cognitive decline in patients with T2DM

More antipsychotic medications prescribed to children and adolescents in Germany

More antipsychotic medications prescribed to children and adolescents in Germany

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint